Dongsheng Biotech (Taixing), located in the Taixing Huangqiao Economic Development Zone, Taixing city, Jiangsu province, has adhered to the dual drivers of digital empowerment and technological innovation to accelerate its bio-fermentation development this year.
As the world's biggest manufacturer of TG enzymes, the company is currently improving its delivery efficiency through intelligent transformation, said Bu Guojian, chairman of the company.
An aerial view of Dongsheng Biotech (Taixing). [Photo/WeChat account: gh_07a864197818]
The company has realized full process visualization management through a central control system to ensure stable and efficient product output.
Bu added that whoever masters advanced technology can control the market, so the company must rely on top talent to seize the advantage.
The company operates a factory spanning 17.13 hectares and has nearly 400 professional technical personnel.
Its annual R&D budget accounts for over 9 percent of the total budget and continues to grow at an annual rate of over 30 percent.
This year, the company's edible gelatin production project, which aims to produce 4,800 metric tons of edible gelatin annually, is expected to further consolidate its leading position in the field of biomanufacturing.
Dongsheng Biotech (Taixing)'s products have a market share of over 30 percent in foreign markets. [Photo/WeChat account: gh_07a864197818]